Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

Cannabis use disorder is frequent in schizophrenia patients, and it is associated with an earlier age of onset and poor schizophrenia prognosis. Serotonin 2A receptors (5‐HT2AR) have been involved in psychosis and, like Akt kinase, are known to be modulated by THC. Likewise, endocannabinoid system d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibarra‐Lecue, Inés, Unzueta‐Larrinaga, Paula, Barrena‐Barbadillo, Rocío, Villate, Aitor, Horrillo, Igor, Mendivil, Begoña, Landabaso, Miguel A., Meana, J. Javier, Etxebarria, Nestor, Callado, Luis F., Urigüen, Leyre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539611/
https://www.ncbi.nlm.nih.gov/pubmed/36301212
http://dx.doi.org/10.1111/adb.13233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539611/
https://www.ncbi.nlm.nih.gov/pubmed/36301212
http://dx.doi.org/10.1111/adb.13233

Ejemplares similares